This comprehensive article provides researchers, scientists, and drug development professionals with an in-depth analysis of catalyst deactivation mechanisms relevant to biomedical applications.
Catalyst deactivation in biosynthetic reactors, primarily through enzyme inactivation and whole-cell biocatalyst decay, represents a critical bottleneck in scaling biopharmaceutical manufacturing.
This comprehensive guide addresses the critical bottlenecks of ribosomal-synthesized and post-translationally modified peptide (RiPP) precursor peptide insolubility and degradation, which hinder in vitro characterization, enzyme engineering, and drug development.
This article provides a detailed exploration of polyketide synthase (PKS) module skipping and stuttering, pivotal yet challenging phenomena in combinatorial biosynthesis.
Non-ribosomal peptide synthetases (NRPS) are enzymatic assembly lines for bioactive compounds, but their complex modular architecture makes them prone to misfolding, hindering engineering efforts for novel therapeutics.
This article provides a comprehensive analysis for researchers and industry professionals on the critical challenge of ATP regeneration in cell-free systems.
This article provides a comprehensive guide to Adaptive Laboratory Evolution (ALE) for enhancing microbial stress tolerance, tailored for researchers, scientists, and drug development professionals.
This comprehensive review explores the pivotal role of the acyl carrier protein (ACP) in the biosynthesis of polyketides, a major class of clinically vital natural products.
This article explores the paradigm shift in materials discovery driven by the integration of active learning and large-scale foundation models.
This article provides a comprehensive analysis of activation energy reduction across major catalyst classes—biological enzymes, heterogeneous solid catalysts, and homogeneous molecular catalysts—tailored for researchers and drug development professionals.